PRT-7732

N/A

Report date: 2026/02/03 20:00:14
NME

Base Information

Drug NamePRT-7732
Drug Alias NamePRT-7732PRT7732
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable global transcription activator SNF2L2 degraders
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsEsophageal adenocarcinomaGastroesophageal Junction NeoplasmsSolid tumours +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaGermany +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPrelude Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrelude Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsEsophageal adenocarcinomaGastroesophageal Junction NeoplasmsSolid tumours +[8] 

Other Information

ATC CodeN/A
Related LinksN/A